Partner Dan Shores will speak on "Understanding the Patent Landscape to Inform Early Delivery Technology Development & Set You Up For Success" at the inaugural RNA Cell Therapies Summit taking place January 24-26, 2023, in Boston, Massachusetts.
Dan's session, to take place on Thursday, January 26, will review the patent landscape, key licensing holders, and cutting edge technologies determining the space to indicate the industry's future trajectory; provide exclusive IP insight to inform the beginning of the technology journey to build value and develop strategies to operate with technologies freely; and discuss existing new technologies to build on differentiation and avoid infringement of existing patents.
RNA technologies have taken the world by storm over the pandemic and now the potential of RNA engineering to enhance cell therapy is finally being realized. The therapeutic potential of RNA CTx is huge, but challenges remain in cell-specific delivery, improving durability of responses, demonstrating safety, and elucidating regulatory considerations to deliver for patients. The inaugural RNA Cell Therapy Summit is the first of its kind to unite 80+ industry and academic pioneers from both the RNA and cell therapy field to bridge-the-gap between transient RNA engineering and cell therapy development.
